Header graphic for print
Dangerous Drugs & Medical Devices News & Commentary on Prescription Drug & Medical Device Lawsuits

Adverse Health Events Related to Metal-on-Metal Hip Replacements

Posted in DePuy Hip Replacement, Stryker Hip Replacement

Metal-on-metal hip replacement (MOM) was introduced in total hip replacement to avoid complications such as osteolysis, the process where bone marrow is not produced, causing weakness in joints and bone structure to occur, a phenomenon often times found in patients with conventional ultra-high molecular weight polyethylene bearings.  This ailment is oftentimes only symptomatic in giving a small amount of joint pain, which often occurs as a minor effect following effective ship replacement surgery, meaning that symptoms of such a serious condition may not lead patients or physicians to notice osteolysis.  Additionally, researchers have noted that often times osteolysis is asymptomatic.  A recent study by Monika Huber, et. al. investigated the rise in reports of osteolysis and other related complications that arise due to the use of MOM hip implants, using implants retrieved post mortem.

The research confirmed previous studies that determined that there may be frequent, unappreciated femoral bone loss in patients with MOM implants, with osteolysis occurring at comparable levels to that of the conventional metal-on-polyethylene implants.  This research indicates that MOM hip replacement may be as dangerous as dated, conventional methods, posing a threat of femoral bone loss, a serious condition often times unnoticed until far after infliction as occurred.

Our lawyers specialize in filing lawsuits for the victims of the adverse effects of metal-on-metal hip replacement.  Please contact us if you or a loved one has suffered from osteolysis or other related ailments due to the surgical use of metal-on-metal hip implants, for we can help secure the justice you deserve.

For a free, no-obligation case consultation, you may reach our offices by phone at (855) 452-5529 or by e-mail at justinian@dangerousdrugs.us.